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Interferon alpha (IFN-a) inhibits hepatitis C virus (HCV) replication in vivo and in cell cultures by one or several mechanisms that are not
yet understood. We sought to identify the viral targets of the IFN-a-induced cellular antiviral program in Huh7 cells expressing HCV
subgenomic replicons. Our results revealed a tight linkage between translation, assembly of replication complexes and viral RNA synthesis,
and indicated that the stability of amplified plus strand RNAwas reduced in the presence of the cytokine. Moreover, HCV internal ribosomal
entry site (IRES)-directed translation was inhibited approximately 2-fold in IFN-treated cells. In contrast, the synthesis of viral RNA did not
seem to be directly affected by the antiviral program induced by the cytokine. Our results were consistent with a model predicting that the
IFN-a-induced antiviral program could inhibit multiple steps of the HCV replication cycle, leading to a reduction in viral protein synthesis
and eventually inhibition of viral RNA amplification.
D 2004 Elsevier Inc. All rights reserved.Keywords: IFN-a; Hepatitis C virus; RNA amplificationIntroduction
Hepatitis C virus (HCV) infections affect the health of
more than 170 million people worldwide and are currently
the most common basis for liver disease in the United
States (Alter and Seeff, 2000). HCV is a member of the
family Flaviviridae, which also includes some well-known
human and animal pathogens, such as yellow fever virus,
West Nile virus, Dengue virus and bovine viral diarrhea
virus (Choo et al., 1989). These viruses have in common a
single-stranded, positive-sense RNA genome carrying one
long open reading frame that is flanked by non-translated
regions (NTR). The HCV genome has a length of about
9600 nucleotides and encodes an approximately 3000-
amino acid-long polyprotein that is proteolytically pro-
cessed into 10 polypeptides (Reed and Rice, 2000). Three
are structural proteins required for capsid formation (core)
and assembly into enveloped viral particles (E1 and E2).0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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ine and serine proteases (NS2 and NS3), an ATP-depen-
dent helicase (NS3) and a RNA-directed RNA polymerase
(NS5B). The functions of the remaining three polypepti-
des, p7, NS4B and NS5A, for viral replication are not yet
known. The 5V NTR spans about 340 nucleotides and
harbors the cis-elements for viral RNA replication and an
internal ribosomal entry site (IRES) directing the transla-
tion of the viral polyprotein. The 3V NTR has a highly
conserved sequence element (3V X) that is essential for
viral RNA replication.
The model for the HCV life cycle predicts that replica-
tion begins with the translation of the polyprotein following
infection of permissive cells. Accumulation of viral proteins
induces rearrangements of ER membranes that form the
locales for replication of viral RNA (Egger et al., 2002;
Westaway et al., 1997). Minus strand RNA synthesis leads
to the formation of a double-stranded RNA molecule that
bears a promoter at the 3V end of minus strand RNA
required for amplification of plus strands by a semiconser-
vative mechanism (Chu and Westaway, 1985). As a conse-
quence of this mechanism, the concentrations of plus and
minus strands differ approximately 10-fold (Chu and West-
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infection, they are transported to ribosomes for additional
rounds of translation and replication of viral RNA. Late in
infection, they are packaged for the production of virus
particles. The mechanism controlling the fate of plus strands
is not yet understood.
Despite several reports claiming that HCV can infect
cultured cells, the levels of viral replication were gener-
ally too low to allow for detailed analyses of viral
replication (i.e. Shimizu et al., 1992; Sung et al., 2003).
The development of selectable subgenomic replicons
facilitated the study of viral replication in cultured cells
and provided a cell-based assay for the screening and
testing of drugs that inhibit viral replication (Lohmann et
al., 1999). Subgenomic replicons carry in lieu of the
structural genes the gene encoding neomycin phospho-
transferase II (NPT II). An IRES derived from EMCV
directs the translation of the non-structural proteins. Rep-
lication of HCV replicons was first demonstrated in the
human hepatoma cell line Huh7, and more recently, in
HeLa and mouse hepatoma cells (Blight et al., 2000;
Lohmann et al., 1999; Zhu et al., 2003). Due to the lack
of structural genes, packaging of plus strand RNA and
assembly of virions cannot occur in the HCV replicon
system and hence, amplified RNA is either reused for
translation or is degraded by cellular ribonucleases.
HCV replication can be inhibited by interferon alpha
(IFN-a) in infected patients and by addition to the
medium of Huh7 cells expressing subgenomic replicons
or full-length genomes (Blight et al., 2000; Frese et al.,
2001; Guo et al., 2001; Neumann et al., 1998). In vivo,
the potency of the cytokine varies significantly depending
on the genotype of the virus and on many other factors
that have not yet been identified (Di Bisceglie and
Hoofnagle, 2002; Kinzie et al., 2001; McHutchison et
al., 1998). IFN-a induces about 300 genes that alter cell
homeostasis and can lead to programmed cell death of
infected cells or inhibition of viral replication (Der et al.,
1998; Sen, 2001; Stark et al., 1998). A recent study with
tissue culture cells revealed that IFN-a can induce cyto-
pathic and non-cytopathic responses in cells expressing
HCV replicons (Guo et al., 2003). However, the cellular
proteins inhibiting HCV replication and the primary target
of IFN-induced antiviral proteins in the HCV replication
cycle have not yet been identified. Several studies
intended to determine whether IFN-a blocks translation
of HCV proteins provided conflicting results, likely
reflecting differences among the experimental systems
used for those analyses (Kato et al., 2002; Koev et al.,
2002; Shimazaki et al., 2002; Wang et al., 2003).
To gain a better understanding of the mechanism by
which IFN-a inhibits HCV replication, we sought to iden-
tify the viral target(s) of the antiviral program elicited by the
cytokine in Huh7 cells. Specifically, we investigated wheth-
er translation, replication complex formation or RNA am-
plification were inhibited by IFN-a.Results and discussion
HCV RNA replication and viral protein synthesis are tightly
linked events
Consistent with previous reports, IFN-a treatment of
Huh7 cells expressing subgenomic replicons, such as the
cell line GS4.1, led to a rapid reduction of viral RNA levels
and, simultaneously, led to an inhibition of viral protein
synthesis (Figs. 1A–C). Inhibition of NPT II and NS5A
synthesis, as measured with 35S-methionine and 35S-cyste-
ine pulse labeling experiments, occurred with similar effi-
ciency, indicating that translation from both, the HCV and
EMCV IRES elements, was affected in a similar manner
(Fig. 1D). Under the same conditions, the translation of
cellular proteins was not affected by IFN-a (results not
shown).
The observed inhibition of translation by IFN-a could
have been caused either directly by inhibition of IRES-
directed translation or indirectly, as a consequence of the
reduction of viral plus strand RNA levels. To distinguish
between these two possibilities, we took advantage of the
nucleoside analogue 2V-C-methyl adenosine (2CMA) that
was previously shown to be an inhibitor of HCV replication
in cells with an IC50 = 0.2 AM. (Carroll et al., 2003).
Incubation of GS4.1 cells with 5 AM 2CMA reduced viral
RNA levels with similar kinetics observed following incu-
bation with 100 IU/ml IFN-a (Fig. 1). In contrast, viral
protein synthesis was more strongly inhibited by 2CMA
than by IFN-a. Notably, the results revealed that 6 h after
incubation of cells with the polymerase inhibitor, RNA
levels decreased by only 20% compared with an 80%
reduction in viral protein synthesis. Similar results were
obtained with two other experiments that were carried out
under similar conditions (results not shown).
These results indicated that translation of viral RNA was
dependent on continuous RNA synthesis and suggested that
only a fraction of plus strands present in cells was used for
the translation of viral proteins. As a consequence of such a
tight linkage between RNA synthesis and protein transla-
tion, it was not possible to directly determine the effects of
IFN-a on HCV translation in a stable replicon cell line.
Effects of IFN-a on HCV IRES-directed translation
To directly measure the effects of IFN-a on IRES-
directed translation, we transfected Huh7 cells with the di-
cistronic reporter plasmids, pHCVneo3 and pEMCVneo6
(Fig. 2A). Pools of transfected cells were incubated for 24
h with different amounts of the cytokine and the levels of
cap- and IRES-dependent translation were determined. The
results showed that at concentrations of IFN-a known to
inhibit HCV RNA replication (10 IU/ml), translation of
NPT II from the EMCV or HCV IRES elements was not
reduced (Fig. 2C). Even at concentrations that exceeded the
IC50 of IFN-a (ca. 1 IU/ml) by 1000-fold, no inhibition of
Fig. 1. HCV RNA levels and protein synthesis in IFN-a- and 2CMA-treated GS4.1 cells. (A) GS4.1 cells were treated with 100 IU/ml IFN-a or 5 AM 2CMA.
Cells were harvested before treatment (0) and 6, 12, 18 and 24 h posttreatment. Viral RNA levels were determined by Northern blot analysis. Ribosomal 28S
RNAwas used as a control for the amount of RNA loaded in each lane. (B and C) GS4.1 cells were cultured in medium alone (control), or medium containing
100 IU/ml IFN-a or 5 AM 2CMA for the indicated time periods. Cells were then pulse-labeled with Express Labeling Mix (NEN) for 2 h. NS5A and NPT II
synthesis were determined by immunoprecipitation assay. (D and E) The amount of viral RNA, NS5A and NPT II were measured with a phosphoimager and
plotted as the fraction (%) of the values obtained with untreated cells.
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for the appearance of the second, faster migrating form of
NPT II is not known. A weak reduction in cap-dependent
synthesis of DHBsAg was apparent at the highest concen-
trations (1000 IU/ml) of the cytokine used for these experi-
ments (Fig. 2B).
Although these results could be interpreted to mean that
IFN-a did not inhibit HCV IRES-directed translation, our
experiments did not preclude the possibility that differences
existed between di-cistronic mRNAs and subgenomic HCV
RNA for translation. For example, it is conceivable that the
proposed interaction between the 5V and 3V NTRs could play
a role in the regulation of IRES-mediated translation (Khro-
mykh et al., 2001). To resolve this problem, we transfected
IFN-a-treated and mock-treated Huh7 cells with in vitro
transcribed subgenomic replicon RNAs and determined the
levels of NPT II translation, which is directed by the HCV
IRES. To distinguish between translation from replicatedRNA and input RNA, we transfected cells with replication-
competent (pZS11) and -deficient (pZS2N) RNAs (Fig. 3).
Translation of NPT II was determined by pulse labeling with
35S-methionine and 35S-cysteine following the electropora-
tion of Huh7 cells that were pretreated with IFN-a for 6 and
12 h, respectively (see Materials and methods). The results
from four experiments showed that IFN-a reduced the
translation of NPT II from pZS11 and pZS2N replicon
RNA to 40–60% of the levels in untreated Huh7 cells
(Figs. 3A and B). The small differences observed between
pZS11 and pZS2N are most likely explained by amplifica-
tion of input RNA in case of the former, but not the latter.
From these results, we concluded that inhibition of
translation could have contributed to the antiviral effects of
IFN-a on HCV replicons in Huh7 cells, but that it was too
weak to explain the antiviral activity of the cytokine. This
view was supported by the observation that RNA replication
could continue in the presence of cycloheximide (CHX), and
Fig. 2. Effects of IFN-a on HCV and EMCV IRES-directed translation in Huh7 cells. (A) Schematic diagrams of bicistronic mRNA. Plasmid pEMCVneo6
encodes a transcript containing the surface antigen gene of duck hepatitis B virus (DHBsAg), EMCV IRES and NPT II gene. Plasmid pHCVneo3 encodes a
transcript containing the surface antigen gene of duck hepatitis B virus (DHBsAg) fused to the HCV IRES (5VNTR) including 36 nt from the core gene and the
complete NPT II gene. In both cases, DHBsAg translation depends on cap-dependent mechanism, but NPT II translations depend on EMCV and HCV IRES,
respectively. (B and C) Huh7 cells were transfected with plasmids pHCVneo3 and pEMCVneo6 by calcium phosphate precipitation procedure (Clontech
Laboratories, Inc.). Forty-eight hours posttransfection, cells were mock-treated or treated with the indicated concentrations of IFN-a for 24 h. Cells were then
pulse-labeled with Express Labeling Mix (NEN) for 2 h. The synthesis of DHBsAg and neomycin NPT II were determined by immunoprecipitation assay.
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RNA declined was much slower than observed with IFN-a
(Fig. 4). The apparent t1/2 of viral RNA in the presence of the
antibiotic was about 20 h, more than twice the time deter-
mined for viral RNA in the presence of IFN-a or 2CMA
(Figs. 4B and 6D). Moreover, results from metabolic label-
ing of viral RNA with 32P-orthophosphate confirmed that
viral RNA synthesis could continue for some time in theabsence of translation and that the inhibition of viral RNA
synthesis by CHX was weaker than observed with IFN-a
(Fig. 5). Those results were consistent with results obtained
from similar experiments with Kunjin virus (Westaway et al.,
1999). Taken together, our results indicated that besides the
inhibition of viral protein translation, the IFN-a induced
antiviral program could also target other steps of the viral
replication cycle, such as viral RNA synthesis, transfer of de
Fig. 3. Effects of IFN-a on HCV IRES-directed translation in Huh7 cells.
(A) Huh7 cells were left untreated (control) or treated with 100 IU/ml of
IFN-a for 6 and 12 h, respectively. Cells were then electroporated with 10
Ag of HCV replicon RNA pZS11 and pZS2N (Zhu et al., 2003). Two hours
after electroporation, cells were pulse-labeled with Express Labeling Mix
(NEN) for 2 h. HCV IRES-directed NPT II synthesis was determined with
an immunoprecipitation assay (upper panel). As a control for the amount of
protein loaded per lane, 1% of the cell lysates were electrophoresed in a
12.5% SDS-PAGE (lower panel). The protein band migrating with a MWof
approximately 15 kDa (arrow) was present in all IFN-a-treated samples and
could represent interferon-stimulated gene 15 (ISG15). (B) NPT II levels
were determined with a Fuji phosphoimager and the mean values and SDs
from four independent assays were plotted.
Fig. 4. Effects of IFN-a and cycloheximide on HCV RNA levels in GS4.1
cells. (A) GS4.1 cells were cultured in medium alone (control), medium
containing 100 IU/ml IFN-a or 20 Ag/ml of cycloheximide for the indicated
time periods. Cells were then harvested and positive strand RNA levels were
determined by Northern blot analysis. Ribosomal 28S RNA was used as a
control for the amount of RNA loaded in each lane. (B) The amounts of HCV
RNAwere determined with a Fuji phosphoimager. PSL, arbitrary units.
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RNA and nonstructural proteins.
Kinetics of HCV RNA decay in cells treated with IFN-a and
an RdRp inhibitor
Assembly of replication complexes and synthesis of
minus strand RNA are the first steps in HCV RNA replica-
tion after translation of the polyprotein. They precede
amplification of plus strand RNA. To determine which of
these steps is inhibited by IFN-a, we measured the rate of
decline of minus and plus strand RNA in the presence of the
cytokine and the polymerase inhibitor 2CMA. In addition,
we took advantage of our previous observation revealing
that HCV replication in Huh7 cells, and other cell lines
examined, is temperature sensitive; that is, replication was
inhibited at temperatures above 37jC (Fig. 6).
The following results were obtained from the analysis of
RNA levels in the presence of three different inhibitors ofHCV replication: first, the rate of decline of plus strand
RNA was consistently highest with IFN-a and was signif-
icantly different (P = 0.02) between IFN and 2CMA (Fig.
6D). Second, minus strands declined at similar rates inde-
pendent of the method used for inhibition of viral replication
with apparent half-lives ranging from 9.5 to 12.3 h (Fig.
6D). These half-lives also reflect the stability of viral
replication complexes consisting of minus and plus strands
in infected cells. Consistent with these results, the half-lives
of the nonstructural proteins were approximately 10–11 h,
indicating that the components of viral replication com-
plexes turn over together at the same or very similar rates
with or without IFN-a (results not shown and Pietschmann
et al., 2001; Wang et al., 2003). The apparent half-lives
calculated from our studies represent maximal values,
because IFN-a or incubation at 39jC did not completely
inhibit viral RNA synthesis (see below and Fig. 8, results
not shown). Third, the rate of decline of plus and minus
strand RNA was different in the presence of all three
inhibitors. In the case of IFN-a and 2CMA, plus strands
declined faster than minus strands (Fig. 6D). Moreover, with
IFN-a, the difference between the half-lives of the two RNA
strands was significant (P = 0.02, Fig. 6D). In contrast,
minus strands declined more rapidly than plus strands at
Fig. 5. Effects of cycloheximide and IFN-a on HCV RNA synthesis in
GS4.1 cells. (A) Cells were left untreated (control) or treated 100 IU/ml of
IFN-a for 6 h and 10 Ag/ml of cycloheximide for 1 h. Cells were then
radiolabeled with 32P-orthophosphate in phosphate-deficient medium alone
(control, IFN-a) or in the presence of 10 Ag/ml of cycloheximide for 3, 6 and
12 h. Total cellular RNA was extracted and electrophoresed through a 1%
agarose gel containing 2.2 M formaldehyde. Normal Huh7 cells were pulse-
labeled for 12 h to serve as negative controls. (B) The amounts of HCV RNA
were determined with a Fuji phosphoimager. PSL, arbitrary units.
J.-T. Guo et al. / Virology 325 (2004) 71–817639jC. Fourth, consistent with these results, differences
between the activities of the three inhibitors became appar-
ent when the ratios between plus and minus strand RNAs
were determined (Table 1). Consistent with the model for
plus strand RNA amplification, in untreated cells, the ratios
varied from 6 to 7.5. In the presence of IFN-a and 2CMA,
the ratio decreased to 2.5 and 3.1, respectively, indicating
that plus strands declined faster than minus strands. In
contrast, complete inhibition of translation by cyclohexi-
mide did not change the ratios between plus and minus
strands. Moreover, inhibition of HCV replication at 39jC
resulted in an increase of the ratio above 9, indicating, as
stated above, that minus strands declined faster than plus
strands under these conditions. However, treatment of cells
with IFN-a at 39jC seemed to reverse the ratio of the two
RNA strands resulting in a pattern observed with IFN alone
(Table 1). This result suggested that these inhibitors (IFN-a,
39jC) blocked HCV replication, at least in part, by distinct
mechanisms.
RNA synthesis in the presence of IFN-a
Our results were consistent with a model predicting that
IFN-a inhibited HCV replication in Huh7 cells by reducing
viral RNA synthesis or through an increase in the turnoverrate of de novo synthesized plus strand RNA, or both. To
better determine the effects of IFN-a on HCV RNA replica-
tion, we measured HCV RNA synthesis in GS4.1 cells
pretreated either with IFN-a for 6 h or with 2CMA by 32P-
orthophosphate metabolic labeling experiments. The selec-
tion of the incubation time with the cytokine was based on
previous experiments showing that IFN-a elicited a complete
antiviral program within 6 h of treatment. The results from
this experiment showed that IFN-a appeared to inhibit RNA
synthesis to nearly the same extent as 2CMA (Fig. 7). The
observed inhibition of RNA synthesis by IFN-a could have
been caused either directly by inhibition of de novo HCV
RNA synthesis or indirectly as a consequence of accelerated
degradation of newly synthesized HCV RNA. Due to the
technical limitations of our experimental system, we were not
able to directly measure the rate of decay of newly synthe-
sized HCV RNA by pulse-chase labeling experiments. In-
stead, we determined the direct effects of IFN-a and 2CMA
on viral RNA synthesis by measuring the RdRp activities in
replication complexes isolated from GS4.1 cells treated
with the cytokine or 2CMA for the indicated time periods.
In Huh7 cells, 2CMA is rapidly converted to 2CMA
triphosphate and efficiently inhibits HCV RNA synthesis
by chain termination (Carroll et al., 2003).
Crude membrane fractions containing replication com-
plexes were analyzed for HCV RdRp activity (Materials and
methods). The results revealed that the RdRp activity and
viral plus strand RNA (vRNA) in the extracts prepared from
IFN-a treated cells declined with a similar rate, indicating
that IFN-a did not directly inhibit HCV RNA synthesis. In
contrast, consistent with the antiviral mechanism of 2CMA,
RdRp activities in the extracts prepared from cells treated
with 2CMA declined much faster than vRNA, indicating, as
expected, a direct block of HCV RNA replication (Fig. 8).
Interestingly, HCV NS5A, a component of HCV replication
complexes, declined with similar rates in membrane frac-
tions prepared from cells treated with IFN-a and 2CMA
(Fig. 8A, lower panel), indicating that in comparison with
2CMA, IFN-a did not accelerate the turnover of HCV RNA
replication complexes, essentially as described above. Our
results showed that RNA synthesis continued in cells treated
with IFN-a and, hence, that the antiviral program induced
by the cytokine did not directly inactivate replication com-
plexes. Such an explanation would imply that the observed
decrease in HCV RNA levels induced by IFN-a in GS4.1
cells (Fig. 7) is primarily due to a decrease in the half-life of
newly synthesized viral RNA.Summary
Over 40 years have passed since the discovery of the
antiviral activity of IFN-a (Isaacs and Lindenmann, 1957).
Yet, the mechanisms by which IFN-induced cellular proteins
inhibit viral replication are in most cases not yet completely
understood. As shown in this study, the lack of an efficient
Fig. 6. Antiviral activity of IFN-a, HCV RNA polymerase inhibitor (2CMA) and heat treatment in GS4.1. (A) GS4.1 cells were treated with 100 IU/ml IFN-a,
5 AM 2CMA or cultured at 39jC and cells were harvested before treatment (0) and 12, 24, 48 and 72 h posttreatment. Total cellular RNAwas extracted with
TRIzol reagent and viral plus strand and minus strand RNA levels present in GS4.1 were determined by Northern blot analysis with strand-specific probes. h-
Actin mRNA served as a control for the amount of RNA loaded per lane. The amounts of HCV plus strand RNA (B) and minus strand RNA (C) were
determined with a Fuji phosphoimager. PSL, arbitrary units. (D) The (apparent) half-life (t1/2) of HCV plus (+) and minus ( ) strand RNAwas calculated with
exponential functions obtained with a curve fitting program (CA-Cricket Graph III) and the results from two to five independent experiments were plotted. The
mean values were indicated with a horizontal bar. Paired t tests were performed with SAS (version 8) software.
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translation, assembly of replication complexes and viral
RNA synthesis hamper efforts to identify the viral targets.
In recognizing the complexity of the problem, we sought to
compare the antiviral activity of IFN-a against HCV repli-
cons with that of inhibitors of the RdRp (2CMA), transla-
tion (cycloheximide) and presumably, assembly or stability
of replication complexes (39jC). Our results showed that
the antiviral activity of the cytokine had at best a 2-fold
effect on HCV IRES-directed translation that could only be
detected with transfected HCV replicon RNA, but not with
bicistronic reporter constructs (Figs. 2 and 3). Moreover, our
results indicated that the IFN response was most likely not
acting on the level of de novo RNA synthesis, although an
effect on the initiation of viral plus and minus strand RNA
could not be excluded (Fig. 8). Our results were consistent
with the possibility that the IFN response accelerated theturnover of plus strand RNA (Figs. 6–8). If RNA degrada-
tion were involved as predicted from our model, we believe
that it was not caused by the double-stranded RNA-depen-
dent RNase L, because our previous studies showed that the
vaccinia virus E3L protein, an inhibitor of double-stranded
RNA-dependent activities, did not block the IFN response
(Guo et al., 2003).
Our results reported here suggested that IFN-a could
inhibit the replication of HCV subgenomes and full-length
genomes in Huh7 cells by multiple antiviral mechanisms
including inhibition of translation, acceleration of viral plus
strand RNA turnover and perhaps, the formation of repli-
cation complexes. Such a model would explain why IFN-a-
resistant HCV replicons could so far not be isolated in IFN-
a treated cells (Guo et al., 2003).
A major question is whether the IFN-a response charac-
terized in Huh7 cells bears any relevance for inhibition of
Table 1
Comparison of the ratios between plus and minus strand RNA in GS4.1
cells incubated with IFN-a, 2CMA at 39jC
Treatment na Time (h)
0 12 24 48
Control 5 7.52 (1.58)b 7.42 (1.26) 7.38 (1.46) 6.78 (1.05)
IFN-a 5 6.76 (1.38) 4.50 (0.65)* 2.64 (0.62)** 2.48 (1.13)**
2CMA 3 6.03 (0.89) 4.83 (0.57) 3.80 (1.47) 3.10 (0.70)*
39jC 3 6.06 (0.55) 6.87 (1.27) 8.87 (2.38) 9.26 (1.45)*
Cycloheximide 3 7.94 (0.87) 7.88 (1.12) 7.85 (1.25)
IFN-a + 39jC 2 6.55 2.3 1.5 1.4
a Number of experiments.
b Mean value (SD).
*P < 0.05 (compared with t = 0).
**P < 0.01 (compared with t = 0).
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of the kinetics of virus inhibition in vivo and in vitro is
difficult, because serial liver biopsy samples cannot be
obtained from IFN-treated patients. Results from microarray
analyses with RNA isolated from chimpanzees during acute
infections revealed a correlation between productive infec-
tion and expression of IFN-induced genes (Bigger et al.,
2001). One possibility that could explain replication of
HCV in the presence of an activated innate immune re-
sponse is that under natural conditions, HCV replicons
exhibit higher stability or replicate more efficiently com-
pared with tissue culture systems and that the antiviral Fig. 8. Effects of IFN-a and 2CMA on HCV RdRp activity. (A) GS4.1 cells
were treated with 100 IU/ml of IFN-a and 10 AM 2CMA and the cells were
harvested before treatment and at 3, 6, 9 and 12 h posttreatment. Untreated
Huh7 cells served as a negative control (lane 11). Crude replication
complexes were prepared and subjected to an RdRp assay under the
conditions described in Materials and methods. RNA products were
extracted and analyzed by denaturing agarose gel electrophoresis (upper
panel). HCV plus strand RNA (vRNA) and NS5A protein in the
preparations of crude replication complexes were determined by Northern
(middle panel) and Western blot analyses (lower panel). (B) The levels of
the RdRp products and HCV RNA (vRNA) were determined with a Fuji
phosphoimager. The RdRp levels were normalized to obtain an RdRp/
vRNA ratio of 1 for the untreated controls shown in lanes 1 and 6.
Fig. 7. Effects of IFN-a and 2CMA on HCV RNA synthesis in GS4.1 cells.
(A) Cells were left untreated (control) or treated 100 IU/ml of IFN-a for 6
h and 5 AM 2CMA for 1 h. Cells were then radiolabeled with 32P-
orthophosphate in phosphate-deficient medium alone (control, IFN-a) or in
the presence of 5 AM 2CMA for 2, 4, 6 and 12 h. Total cellular RNAwere
extracted and electrophoresed through a 1% agarose gel containing 2.2 M
formaldehyde. Normal Huh7 cells were pulse-labeled for 12 h to serve as
negative controls. (B) The amounts of HCV RNA were determined with a
Fuji phosphoimager. PSL, arbitrary units.program induced by IFN-a as described in this report
functions to constrain an RNA amplification scheme
designed for exponential expansion of viral RNA, as it
occurs with most other positive-stranded RNA viruses. In
fact, such a model would explain why HCV is a non-
cytolytic virus that appears to replicate at very low levels
in infected hepatocytes.Materials and methods
Chemicals and reagents
Recombinant interferon-a 2b (Intron A) was purchased
from Schering-Plough. The HCV RNA-dependent RNA
polymerase (RdRp) inhibitor 2V-C-methyladenosine
(2CMA) (Carroll et al., 2003) was obtained from Dr.
J.-T. Guo et al. / Virology 325 (2004) 71–81 79Joanne E. Tomassini (Merck Research Laboratories, West
Point, PA).
Cell culture
The GS4.1 cell line is a subclone derived from cell line
FCA1 expressing HCV subgenomic replicon I377NS3-3V
(Guo et al., 2001). Cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, penicillin G, streptomycin, non-
essential amino acids, L-glutamine and 500 Ag/ml G418.
Plasmids
Plasmid pEMCVneo6 was generated as follows. pIRES-
neo3 (Clontech) was digested with EcoRI and filled in with
Klenow enzyme and then digested with NdeI. The vector
fragment was recovered and ligated with a NdeI and MluI-
restricted PCR fragment containing the gene for the surface
antigen of duck hepatitis B virus (DHBsAg), amplified from
plasmid pSP65DHBVgal5.1 (Pugh et al., 1987) using the
oligonucleotide primer pairs: 5V-AAAAGCTAGCGGTGC-
CAGTGATGGAAACTC-3V and 5V-AAAAACGCGTT-
TAAACTGGTAACCGAGGAATCTTAT-3V. To construct
plasmid pHCVneo3, pEMCVneo6 was digested with PmeI
and XbaI. The vector fragment was recovered and ligated
with a BamHI and XbaI-restricted PCR fragment containing
the HCV IRES and NPT II gene, amplified from plasmid
HCV-SPI (I377/NS3-3 V) (Guo et al., 2001) using
the oligonucleotide primer pairs: 5V-TTTTGGATCCGA
CTCACTATAGCCAGCC-3 V and 5 V-TTTTTCTA-
GAAACCGTTGTGGTCTGTTTA-3V. Because an addition-
al 36 nt derived from the HCV core gene was fused to the 5V
end of the NPT II gene, the size of the NPT II protein
expressed with pHCVneo3 was increased by12 amino acids
compared to pEMCVneo6.
RNA extraction and Northern blot hybridization
Total cellular RNA was extracted with TRIzol reagent
(Invitrogen). Five micrograms of total RNA was electro-
phoresed through a 1% agarose gel containing 2.2 M
formaldehyde and transferred onto Nylon membranes.
Membranes were hybridized with riboprobes specific for
plus and minus strands of HCV replicon RNA and h-actin
mRNA as described previously (Guo et al., 2001).
Metabolic labeling of protein synthesis and
immunoprecipitation
GS4.1 and Huh7 cells were seeded into 60-mm Petri
dishes at a density of 4  105 cells per dish and maintained
in complete DMEM. After 60 h of incubation, the cell
monolayers were washed with PBS and incubated with
methionine and cysteine-free DMEM medium (Sigma) for
1 h. Culture medium was replaced with 1 ml of methionineand cysteine-free DMEM medium supplemented with Ex-
press Labeling Mix (200 ACi/ml, NEN) and incubated for
the indicated time periods. The medium was removed and
the cells were washed with PBS and lysed with 1 ml of cell
lysis buffer (20 mM Tris–HCl, pH 7.5, 100 mM NaCl, 1
mM EDTA, 1% NP40, 1% DOC, 0.01% SDS, 1 mM PMSF,
40 Ag/ml leupeptin and 100 Ag/ml TPCK) in ice. The cell
lysates were cleared by centrifugation at 15,000  g for 5
min at 4jC. SDS and trichloroacetic acid (TCA) were added
to the supernatants of cell lysates to final concentrations of
2% and 5%, respectively. The supernatants were incubated
on ice for 30 min and then centrifuged at 12,000 rpm for 5
min at 4jC. Supernatants were carefully removed and
pellets were dissolved in 60 Al of protein sample buffer
(200 mM Tris–HCl, pH 8.8, 5 mM EDTA, 2% SDS, 1% 2-
mercaptoethanol, 10% sucrose and 0.1% bromophenol blue)
and boiled for 5 min and diluted with 1.2 ml of RIPA buffer
(PBS supplemented with 1% NP40 and 1% DOC). For
immunoprecipitation of HCV NS5A protein, 25 Al (packed
volume) rabbit anti-mouse IgG pre-absorbed SPA-sepharose
4B beads was added to 0.5 ml of cell lysate and incubated
for at least 2 h at 4jC with agitation, centrifuged and the
supernatant was transferred into a new tube. One microgram
of anti-NS5A monoclonal antibody (a gift of Dr. Chen Liu,
University of Florida, Gainesville, FL) and 25 Al (packed
volume) rabbit anti-mouse IgG pre-absorbed SPA-sepharose
4B beads were added into the supernatants and incubated at
4jC overnight with agitation. Beads were washed five times
with RIPA buffer. The same method was used for the
immunoprecipitation of NPT II, except that 25 Al rabbit
anti-NPT II antibody pre-absorbed SPA-sepharose 4B beads
was used. Forty microliters of 2 SDS-PAGE gel loading
buffer was added and samples were boiled for 5 min. The
proteins were electrophoresed through a 10% SDS-PAGE.
The gels were fixed with 40% methanol and 10% glacial
acetic acid for 30 min and incubated with ENHANCER
solution (Amersham) for 30 min. The gels were dried and
exposed to Fuji phosphoimager plates and X-ray films.
DNA and RNA transfections
Plasmid pHCVneo3 and pEMCVneo6 were transfected
into Huh7 cell cells by calcium phosphate precipitation
procedure (Clontech Laboratories, Inc.). Seventy-two hours
posttransfection, cells were pulse-labeled with methionine
and cystine-free DMEM medium supplemented with Ex-
press Labeling Mix (200 ACi/ml, NEN) for 2 h. The
synthesis of DHBsAg and NPT II were determined by
immunoprecipitation with a monoclonal antibody 7C12
(Guo and Pugh, 1997) and a polyclonal antibody against
NPT II (US Biotech), respectively.
To determine the effects of IFN-a on HCV IRES-
directed translation in the context of viral replicon RNA,
Huh7 cells were mock-treated or treated with 100 IU/ml of
IFN-a for 6 or12 h. The cells were trypsinized and electro-
porated with 10 Ag of HCV replicon RNA in vitro tran-
J.-T. Guo et al. / Virology 325 (2004) 71–8180scribed from plasmids pZS11 and ZS2N (Zhu et al., 2003)
as described previously (Guo et al., 2001). After electro-
poration, cells were seeded onto 60-mm dishes. Two hours
later, unattached cells were removed and NPT II synthesis
was determined by pulse labeling with Express Labeling
Mix (200 ACi/ml, NEN) for 2 h and immunoprecipitation
with a polyclonal antibody against NPT II.
Metabolic labeling of HCV RNA
GS4.1 and Huh7 cells were seeded into 60-mm Petri
dishes at a density of 4  105 cells per dish and
maintained with complete DMEM. After 48 h of incuba-
tion, cell monolayers were washed with PBS and incubated
with phosphate-free DMEM medium (ICN) supplemented
with 5% dialyzed fetal bovine serum, 1/20th the normal
concentration of phosphate and 5 Ag/ml actinomycin D for
1 h. Culture medium was replaced with 1 ml of phosphate-
free DMEM medium supplemented with 5% dialyzed FCS,
1/20th the normal concentration of phosphate, 5 Ag/ml
actinomycin D and 32P-orthophosphate (200 ACi/ml, ICN,
cat. number 64014) and incubated for the indicated time
periods. Cells were harvested by carefully aspirating me-
dium and washing with PBS. Total cellular RNA was
extracted with TRIzol reagent (Invitrogen) and electro-
phoresed through a 1% agarose gel containing 2.2 M
formaldehyde. The gels were soaked in 10% glacial acetic
acid for 20 min to remove acid-soluble 32P and dehydrated
in 95% ethanol for 20 min. The gels were dried with a gel
drier at 50jC for 2–3 h and exposed to Fuji phosphoim-
ager plates.
HCV RdRp assay
GS4.1 and Huh7 cells were treated with IFN-a and
2CMA for the indicated time periods and then washed with
PBS. Cells were collected with a rubber policeman and
suspended in TNMg buffer (10 mM Tris–HCl, pH 8.0, 10
mM sodium acetate and 0.5 mM MgCl2) at a density of 3 
107 cells/ml and incubated on ice for 10 min. The swollen
cells were further lysed by passing through 20-gauge needle
30 times and 26-gauge needle 60 times. The cell lysate were
fractionated by centrifugation at 500  g for 5 min to
remove nuclei and supernatants were then centrifuged at
10,000  g for 10 min to pellet the membrane fraction
containing HCV replication complexes. The pellet was
resuspended in TNMg buffer. The reaction mixtures of
HCV RdRp assay contained the following: 50 mM Tris–
HCl (pH 8.0), 10 mM sodium acetate, 7.5 mM potassium
acetate, 10 mM h-mercaptoethanol, 400 U/ml RNasin, 6 Ag/
ml actinomycin D, 0.5 mM of ATP, CTP and UTP, 25 AM
GTP, 0.5 mCi/ml of a-32P-GTP, 5 mM phosphopyruvate, 15
U/ml of pyruvate kinase (Sigma), 34 Al of membrane
fraction from ca. 106 cells and H2O to a total volume of
50 Al. Reactions were incubated at 30jC for 60 min. RNA
was extracted with TRIzol reagent and electrophoresedthrough a 1% agarose gel containing 2.2 M formaldehyde.
The dried gels were exposed to Fuji phosphoimager plates.
Western blot analysis
Five microliters of the membrane fractions from ca. 105
GS4.1 or Huh 7 cells were combined with an equal volume
of 2 SDS-PAGE sample buffer. The proteins were sepa-
rated on 10% SDS-polyacrylamide gels and electrophoret-
ically transferred to Immobilon-P membranes (Millipore
Corp.). The membranes were first incubated with a mono-
clonal antibody against HCV NS5A and then incubated with
horseradish peroxidase-conjugated goat anti-mouse immu-
noglobulin G (IgG) (Amersham) and bound IgG was
detected with Super-Signal chemiluminescence reagents
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